ENAapplication/xmlftp.sra.ebi.ac.uk/vol1/fastq/SRR706/007/SRR7063187/SRR7063187_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/009/SRR7063179/SRR7063179_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/005/SRR7063185/SRR7063185_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/003/SRR7063183/SRR7063183_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/006/SRR7063186/SRR7063186_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/004/SRR7063184/SRR7063184_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/000/SRR7063180/SRR7063180_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/009/SRR7063179/SRR7063179_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/004/SRR7063184/SRR7063184_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/003/SRR7063183/SRR7063183_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/001/SRR7063181/SRR7063181_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/005/SRR7063185/SRR7063185_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/002/SRR7063182/SRR7063182_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/000/SRR7063180/SRR7063180_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/002/SRR7063182/SRR7063182_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/007/SRR7063187/SRR7063187_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/001/SRR7063181/SRR7063181_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR706/006/SRR7063186/SRR7063186_2.fastq.gzprimaryOK2000000GenomicsSt. Jude Children's Research Hospitalhttps://www.ebi.ac.uk/ena/browser/view/PRJNA453548Homo sapiensSingle cell RNA-seq of the human alveolar rhabdomyosarcoma cell line Rh41. We also inlcude a bulk RNA-seq study of unsorted and sorted cells using CD44 as a marker Overall design: Single cell RNA-seq of Rh41 using the 10x Genomics. For bulk RNA-seq, there are three batches, each corresponds to three samples: sorted CD44 high, sorted CD44 low and unsorted. C2, C6, C7: CD44high subspopulation (Batch 1/2/3); C3, C4, C5: CD44low subpopulation (Batch 1/2/3); C1, C8, C9: CD44 unsorted (Batch 1/2/3)ENARNA, dTAF[[II]]230, TAF[[II]]250, d230, RNA Sequence Determination, determination, RNA Sequence Determinations, Sequence Determination, RNA Sequence, TAF200, l(3)84Ab, dTAFII250, BG:DS00004.13, TAFII-250, TAF250/230, EfW1, Cell, Determinations, dTAF230, dmTAF[[II]]230, TAFII250, count, dmTAF1, Taf230, p230, chemical analysis, TAF[[II]]250/230, TFIID, Analysis, TAF250, Taf[[II]]250, Taf200, dTAF[[II]]250, TAF[[II]]230, TFIID TAF250, Analyses, cel, Determination, cell, Taf1p, TAF[II]250, CG17603, TAF[[II]], Sequence Determinations, Sequencing, dTAF250, DmelCG17603, Taf250, RNA Sequence Analyses, SR3-5, RNA Sequence Analysis, RNA., RNA Sequencing, assay, TAF, TAF230, TAF1, Sequence AnalysesRNA, dTAF[[II]]230, TAF[[II]]250, d230, RNA Sequence Determination, determination, RNA Sequence Determinations, Sequence Determination, RNA Sequence, TAF200, l(3)84Ab, dTAFII250, BG:DS00004.13, TAFII-250, TAF250/230, EfW1, Cell, Determinations, dTAF230, dmTAF[[II]]230, TAFII250, count, dmTAF1, Taf230, p230, chemical analysis, TAF[[II]]250/230, TFIID, Analysis, TAF250, Taf[[II]]250, Taf200, dTAF[[II]]250, TAF[[II]]230, TFIID TAF250, Analyses, cel, Determination, cell, Taf1p, TAF[II]250, CG17603, TAF[[II]], Sequence Determinations, Sequencing, dTAF250, DmelCG17603, Taf250, RNA Sequence Analyses, SR3-5, RNA Sequence Analysis, RNA., RNA Sequencing, assay, TAF, TAF230, TAF1, Sequence Analyses0.00.00.00.00.00falseUMI-count modeling and differential expression analysis for single-cell RNA sequencingUMI-count modeling and differential expression analysis for single-cell RNA sequencing2022-07-192018-05-01PRJNA453548GSE11366029855333315662339606